Pharmacist-led transitions of care between hospitals, primary care clinics, and community pharmacies.
medication management
older adults
pharmacist
primary care clinics
transitions of care
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
26
10
2021
received:
17
07
2021
accepted:
30
10
2021
pubmed:
25
11
2021
medline:
4
5
2022
entrez:
24
11
2021
Statut:
ppublish
Résumé
Pharmacist-led transitions of care (TOC) interventions have been described as some of the most promising interventions to reduce medication-related harm (MRH) in older adults. This study analyzed the feasibility of pharmacist-led TOC interventions between hospitals, multidisciplinary primary care clinics (PCC), and community pharmacies. Adults aged 65 years and older at risk of MRH in three regions of Quebec, Canada, with contrasting contexts of care based on university affiliation were recruited in this multicenter, single arm, and prospective intervention cohort. The hospital pharmacist developed the pharmaceutical care plan in collaboration with the hospital physician and transferred this plan with the hospitalization summary, at hospital discharge, to the PCC family physician and to the community and PCC pharmacists. A consultation with the community pharmacist was scheduled within seven days of hospital discharge and with the PCC pharmacist when appropriate. Feasibility outcomes included the time to complete the interventions and their location. The 123 eligible patients had a mean age of 78.5 years, and 63.4% were females. The most frequent inclusion criterion was 10 medications or more, including one high-risk medication for 90 patients (73%). Recruitment in one region was stopped after three months due to unsuccessful recruitment of key PCC. The hospital pharmacist interventions took a median of 165 min. The first consultations of the PCC and community pharmacists took a median of 15 and 50 min. Among the 96 patients with a post-discharge pharmacist follow-up, 23 (24.0%) had a consultation with a PCC pharmacist, with 65.2% of the consultations conducted at the PCC. The community pharmacists conducted a consultation with 88 patients (93%), with more than 70% of consultations conducted by phone. Our study showed the feasibility of pharmacist-led TOC interventions between hospitals, PCC, and community pharmacies and detailed the novel role that PCC pharmacists played in optimizing TOC interventions.
Sections du résumé
BACKGROUND
Pharmacist-led transitions of care (TOC) interventions have been described as some of the most promising interventions to reduce medication-related harm (MRH) in older adults. This study analyzed the feasibility of pharmacist-led TOC interventions between hospitals, multidisciplinary primary care clinics (PCC), and community pharmacies.
METHODS
Adults aged 65 years and older at risk of MRH in three regions of Quebec, Canada, with contrasting contexts of care based on university affiliation were recruited in this multicenter, single arm, and prospective intervention cohort. The hospital pharmacist developed the pharmaceutical care plan in collaboration with the hospital physician and transferred this plan with the hospitalization summary, at hospital discharge, to the PCC family physician and to the community and PCC pharmacists. A consultation with the community pharmacist was scheduled within seven days of hospital discharge and with the PCC pharmacist when appropriate. Feasibility outcomes included the time to complete the interventions and their location.
RESULTS
The 123 eligible patients had a mean age of 78.5 years, and 63.4% were females. The most frequent inclusion criterion was 10 medications or more, including one high-risk medication for 90 patients (73%). Recruitment in one region was stopped after three months due to unsuccessful recruitment of key PCC. The hospital pharmacist interventions took a median of 165 min. The first consultations of the PCC and community pharmacists took a median of 15 and 50 min. Among the 96 patients with a post-discharge pharmacist follow-up, 23 (24.0%) had a consultation with a PCC pharmacist, with 65.2% of the consultations conducted at the PCC. The community pharmacists conducted a consultation with 88 patients (93%), with more than 70% of consultations conducted by phone.
CONCLUSION
Our study showed the feasibility of pharmacist-led TOC interventions between hospitals, PCC, and community pharmacies and detailed the novel role that PCC pharmacists played in optimizing TOC interventions.
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
766-776Informations de copyright
© 2021 The American Geriatrics Society.
Références
Krumholz HM. Post-hospital syndrome - a condition of generalized risk. N Engl J Med. 2013;368(2):100-102. doi:10.1056/NEJMp1212324
Parekh N, Ali K, Page A, Roper T, Rajkumar C. Incidence of medication-related harm in older adults after hospital discharge: a systematic review. J Am Geriatr Soc. 2018;66(9):1812-1822. doi:10.1111/jgs.15419
World Health Organization. Medication Without Harm - Global Patient Safety Challenge on Medication Safety. 2017. Licence: CC BY-NC-SA 3.0 IGO. Accessed October 24, 2021. https://www.who.int/initiatives/medication-without-harm
Steinman MA. Reducing hospital admissions for adverse drug events through coordinated pharmacist care: learning from Hawai'i without a field trip. BMJ Qual Saf. 2019;28(2):91-93. doi:10.1136/bmjqs-2018-008815
Rodrigues CR, Harrington AR, Murdock N, et al. Effect of pharmacy-supported transition-of-care interventions on 30-day readmissions: a systematic review and meta-analysis. Ann Pharmacother. 2017;51(10):866-889. doi:10.1177/1060028017712725
Gurwitz JH, Kapoor A, Garber L, et al. Effect of a multifaceted clinical pharmacist intervention on medication safety after hospitalization in persons prescribed high-risk medications: a randomized clinical trial. JAMA Intern Med. 2021;181(5):610-618. doi:10.1001/jamainternmed.2020.9285
Ensing HT, Stuijt CCM, van den Bemt BJF, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614-636. doi:10.18553/jmcp.2015.21.8.614
Bethishou L, Herzik K, Fang N, Abdo C, Tomaszewski DM. The impact of the pharmacist on continuity of care during transitions of care: a systematic review. J Am Pharm Assoc (2003). 2020;60(1):163-177.e2. doi:10.1016/j.japh.2019.06.020
Kooyman CDA, Witry MJ. The developing role of community pharmacists in facilitating care transitions: a systematic review. J Am Pharm Assoc (2003). 2019;59(2):265-274. doi:10.1016/j.japh.2018.11.009
Daliri S, Boujarfi S, El Mokaddam A, et al. Medication-related interventions delivered both in hospital and following discharge: a systematic review and meta-analysis. BMJ Qual Saf. 2021;30(2):146-156. doi:10.1136/bmjqs-2020-010927
Pellegrin KL, Krenk L, Oakes SJ, et al. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J Am Geriatr Soc. 2017;65(1):212-219. doi:10.1111/jgs.14518
Ensing HT, Koster ES, Dubero DJ, van Dooren AA, Bouvy ML. Collaboration between hospital and community pharmacists to address drug-related problems: the HomeCoMe-program. Res Social Adm Pharm. 2019;15(3):267-278. doi:10.1016/j.sapharm.2018.05.001
Wright EA, Graham JH, Maeng D, et al. Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up. J Am Pharm Assoc (2003). 2019;59(2):178-186. doi:10.1016/j.japh.2018.11.005
Criddle DT. Effect of a pharmacist intervention. Ann Intern Med. 2013;158(2):137. doi:10.7326/0003-4819-158-2-201301150-00013
Dolovich L. Ontario pharmacists practicing in family health teams and the patient-centered medical home. Ann Pharmacother. 2012;46(4):S33-S39. doi:10.1345/aph.1Q804
Guénette L, Maheu A, Vanier M-C, Dugré N, Rouleau L, Lalonde L. Pharmacists practising in Family Medicine Groups: what are their activities and needs? J Clin Pharm Ther. 2020;45(1):105-114. doi:10.1111/jcpt.13035
Tan ECK, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608-622. doi:10.1016/j.sapharm.2013.08.006
Hazen ACM, de Bont AA, Boelman L, et al. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: a systematic review. Res Social Adm Pharm. 2018;14(3):228-240. doi:10.1016/j.sapharm.2017.04.014
Freeman CR, Scott IA, Hemming K, et al. Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME): a stepped wedge, cluster randomised controlled trial. Med J Aust. 2021;214(5):212-217. doi:10.5694/mja2.50942
Cossette B, Ricard G, Poirier R, et al. Pharmacist-led transitions of care for older adults at risk of drug-related problems: a feasibility study. Res Social Adm Pharm. 2021;17:1276-1281. doi:10.1016/j.sapharm.2020.09.013
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674-694. doi:10.1111/jgs.15767
Buchholz I, Janssen MF, Kohlmann T, Feng Y-S. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36(6):645-661. doi:10.1007/s40273-018-0642-5
Ensing HT, Koster ES, van Berkel PI, van Dooren AA, Bouvy ML. Problems with continuity of care identified by community pharmacists post-discharge. J Clin Pharm Ther. 2017;42(2):170-177. doi:10.1111/jcpt.12488
Eibergen L, Janssen MJA, Blom L, Karapinar-Çarkit F. Informational needs and recall of in-hospital medication changes of recently discharged patients. Res Social Adm Pharm. 2018;14(2):146-152. doi:10.1016/j.sapharm.2017.01.006
Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2(6):e001461. doi:10.1136/bmjopen-2012-001461
Weir DL, Motulsky A, Abrahamowicz M, et al. Failure to follow medication changes made at hospital discharge is associated with adverse events in 30 days. Health Serv Res. 2020;55(4):512-523. doi:10.1111/1475-6773.13292
Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care-a large-scale follow-up study. Eur J Clin Pharmacol. 2007;63(8):783-790. doi:10.1007/s00228-007-0325-1
Daliri S, Hugtenburg JG, Ter Riet G, et al. The effect of a pharmacy-led transitional care program on medication-related problems post-discharge: a before-After prospective study. PLoS One. 2019;14(3):e0213593. doi:10.1371/journal.pone.0213593
McCarthy LM, Li S, Fernandes O, et al. Enhanced communication between inpatient and community pharmacists to optimize medication management during transitions of care. J Am Pharm Assoc (2003). 2019;59(1):79-86.e1. doi:10.1016/j.japh.2018.09.006
Dolan MA, Renfro CP, Ferreri SP, Shilliday BB, Ives TJ, Cavanaugh JJ. Community pharmacist preferences in transition of care communications. J Pharm Pract. 2019;32(5):524-528. doi:10.1177/0897190018770551
Brühwiler LD, Hersberger KE, Lutters M. Hospital discharge: what are the problems, information needs and objectives of community pharmacists? a mixed method approach. Pharm Pract. 2017;15(3):1046. doi:10.18549/PharmPract.2017.03.1046
Zeleznikar EA, Kroehl ME, Perica KM, Thompson AM, Trinkley KE. Integration of community pharmacists in transition of care (TOC) services: current trends and pharmacist perceptions. J Pharm Pract. 2019;32(1):28-35. doi:10.1177/0897190017735976
Pellegrin K, Chan F, Pagoria N, Jolson-Oakes S, Uyeno R, Levin A. A statewide medication management system: health information exchange to support drug therapy optimization by pharmacists across the continuum of care. Appl Clin Inform. 2018;9(1):1-10. doi:10.1055/s-0037-1620262
Ecarot T, Fraikin B, Lavoie L, McGilchrist M, Ethier J-F. A sensitive data access model in support of learning health systems. Comput Secur. 2021;10(3):25. doi:10.3390/computers10030025